MODY is a sub-type of NIDDM. It is characterized by an early age of on
set and autosomal dominant mode of inheritance. These features, and th
e availability of large multigenerational pedigrees, make MODY useful
for genetic studies of diabetes. In the large ii-generational RW pedig
ree, MODY is tightly linked to genetic markers on chromosome 20q. Affe
cted subjects in this family show abnormalities of carbohydrate metabo
lism, varying from impaired glucose tolerance (IGT) to severe diabetes
. Approximately 30 % of diabetic subjects become insulin-requiring, an
d vascular complications occur. MODY is also linked to the glucokinase
gene on chromosome 7p and many different mutations associated with MO
DY have been identified in this gene. MODY, due to mutations in the gl
ucokinase gene, is a relatively mild form of diabetes with mild fastin
g hyperglycaemia and IGT in the majority. Clinical investigative studi
es indicate that the genetic or primary defect in MODY is characterize
d by deranged and deficient insulin secretion and not by insulin resis
tance. There are quantitative and qualitative differences in insulin s
ecretory defects which differentiate subjects with MODY due to mutatio
n in the gene on chromosome 20q from those with glucokinase mutations.
These differences correlate with the severity of diabetes between the
se two genetic forms of MODY.